Excelsior Biopharma Inc. (6496.TWO)

TWD 26.9

(1.7%)

Operating Income Summary of Excelsior Biopharma Inc.

  • Excelsior Biopharma Inc.'s latest annual operating income in 2023 was -81.12 Million TWD , down -194.72% from previous year.
  • Excelsior Biopharma Inc.'s latest quarterly operating income in 2024 Q2 was -16.61 Million TWD , up 42.5% from previous quarter.
  • Excelsior Biopharma Inc. reported an annual operating income of -25.31 Million TWD in 2022, down -2384.3% from previous year.
  • Excelsior Biopharma Inc. reported an annual operating income of -1.01 Million TWD in 2021, down -102.18% from previous year.
  • Excelsior Biopharma Inc. reported a quarterly operating income of -31.78 Million TWD for 2024 Q1, down -387.31% from previous quarter.
  • Excelsior Biopharma Inc. reported a quarterly operating income of 11.06 Million TWD for 2023 Q4, up 134.53% from previous quarter.

Annual Operating Income Chart of Excelsior Biopharma Inc. (2023 - 2019)

Historical Annual Operating Income of Excelsior Biopharma Inc. (2023 - 2019)

Year Operating Income Operating Income Growth
2023 -81.12 Million TWD -194.72%
2022 -25.31 Million TWD -2384.3%
2021 -1.01 Million TWD -102.18%
2020 46.78 Million TWD -46.09%
2019 86.77 Million TWD 0.0%

Peer Operating Income Comparison of Excelsior Biopharma Inc.

Name Operating Income Operating Income Difference
Allied Biotech Corporation 88.71 Million TWD 191.449%
GeneFerm Biotechnology Co., Ltd. 153.56 Million TWD 152.83%
Easywell Biomedicals, Inc. -162.73 Million TWD 50.148%
TTY Biopharm Company Limited 1.37 Billion TWD 105.911%
Synmosa Biopharma Corporation 614.74 Million TWD 113.197%
Orient EuroPharma Co., Ltd. 84.55 Million TWD 195.948%
Center Laboratories, Inc. -79.26 Million TWD -2.35%
Tien Liang BioTech Co., Ltd. 20.43 Million TWD 496.986%
Orient Pharma Co., Ltd. 27.75 Million TWD 392.322%
InnoPharmax Inc. -64.83 Million TWD -25.122%
Johnson Chemical Pharmaceutical Works Co., Ltd. 105.57 Million TWD 176.847%
DV Biomed Co., Ltd. 173.54 Million TWD 146.746%
Foresee Pharmaceuticals Co., Ltd. -1 Billion TWD 91.949%
Handa Pharmaceuticals, Inc. 695.79 Million TWD 111.66%
UniPharma Co., Ltd. -27.3 Million TWD -197.118%
Anxo Pharmaceutical Co., Ltd. 53.15 Million TWD 252.631%
Alar Pharmaceuticals Inc. 385.52 Million TWD 121.043%
Winston Medical Supply Co., Ltd. 196.1 Million TWD 141.371%
Mercury Biopharmaceutical Corporation -45.69 Million TWD -77.562%
Bioray Biotech Co., Ltd -19.33 Million TWD -319.678%
TSH Biopharm Corporation Limited 63.63 Million TWD 227.5%